Petiole USA’s Synovus SNV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-70,063
| Closed | -$3.51M | – | 33 |
|
|
2025
Q4 | $3.51M | Hold |
70,063
| – | – | 2.27% | 19 |
|
|
2025
Q3 | $3.44M | Sell |
70,063
-6,190
| -8% | -$317K | 2.38% | 16 |
|
|
2025
Q2 | $3.95M | Hold |
76,253
| – | – | 2.79% | 14 |
|
|
2025
Q1 | $3.56M | Hold |
76,253
| – | – | 2.52% | 16 |
|
|
2024
Q4 | $3.91M | Hold |
76,253
| – | – | 2.46% | 15 |
|
|
2024
Q3 | $3.39M | Hold |
76,253
| – | – | 2.22% | 20 |
|
|
2024
Q2 | $3.06M | Sell |
76,253
-19,065
| -20% | -$723K | 2.57% | 17 |
|
|
2024
Q1 | $3.82M | Hold |
95,318
| – | – | 2.99% | 15 |
|
|
2023
Q4 | $3.59M | Hold |
95,318
| – | – | 2.65% | 17 |
|
|
2023
Q3 | $2.65M | Hold |
95,318
| – | – | 2.43% | 17 |
|
|
2023
Q2 | $2.88M | Hold |
95,318
| – | – | 2.82% | 15 |
|
|
2023
Q1 | $2.94M | Sell |
95,318
-19,335
| -17% | -$736K | 2.46% | 18 |
|
|
2022
Q4 | $4.31M | Sell |
114,653
-160
| -0.1% | -$6.35K | 3.15% | 12 |
|
|
2022
Q3 | $4.31M | Buy |
114,813
+27,500
| +31% | +$1.09M | 3.2% | 12 |
|
|
2022
Q2 | $3.15M | Hold |
87,313
| – | – | 2.75% | 17 |
|
|
2022
Q1 | $4.28M | Hold |
87,313
| – | – | 3.31% | 13 |
|
|
2021
Q4 | $4.18M | Buy |
+87,313
| New | +$4.13M | 3% | 15 |
|
Other funds holding SNV
Petiole USA's SNV Position: Q1 2026 in Review
Petiole USA sold out of Synovus (SNV) in Q1 2026, closing a stake of 70,063 shares — an estimated $3.51M sold.
Petiole USA first reported a position in SNV in Q4 2021 and held it in 17 quarters. The position peaked at $4.31M in Q3 2022. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.
- Petiole USA reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
- Petiole USA sold 70,063 Synovus shares in Q1 2026, an estimated $3.51M.
- Petiole USA first reported a position in Synovus in Q4 2021 and held it in 17 quarters.
- Petiole USA's Synovus position peaked at $4.31M in Q3 2022.
- 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.
Based on Petiole USA's 13F filing for Q1 2026, filed 14 May 2026.